EMD-70812

Single-particle
2.67 Å
EMD-70812 Deposition: 26/05/2025
Map released: 17/09/2025
Last modified: 01/10/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-70812

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9osw summary report (pdf.gz) Map-9osw FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Tetrameric POLQ Helicase-like Domain Bound to Cmpd 19, a Small-Molecule ATPase Inhibitor and Drug Candidate Analog

EMD-70812

Single-particle
2.67 Å
EMD-70812 Deposition: 26/05/2025
Map released: 17/09/2025
Last modified: 01/10/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens
Sample: Polymerase theta N-terminal domain in complex with ATPase inhibitor compound
Fitted models: 9osw

Deposition Authors: Zahn KE , Scapin G
The Discovery of RP-2119: A Potent, Selective, and Orally Bioavailable Pol theta ATPase Inhibitor.
PUBMED: 40920169
DOI: doi:10.1021/acs.jmedchem.5c02103
ISSN: 0022-2623
ASTM: JMCMAR
Grant Support: